Predictive Oncology Inc. Common Stock (POAI)
Predictive Oncology Inc. (POAI) is a biotechnology company specializing in using artificial intelligence and data analytics to develop personalized cancer treatments. The company focuses on leveraging genomic and clinical data to identify targeted therapies, aiming to improve outcomes for cancer patients through tailored medicine solutions.
Company News
Predictive Oncology raised $343.5 million through private placements to support a digital asset treasury strategy focused on Aethir's ATH token, aiming to enhance computational capabilities for AI-driven drug discovery.
U.S. stocks traded higher with Nasdaq gaining 150 points. Pending home sales surged 4% in August, marking the sharpest gain in five months. Several biotech companies experienced significant stock price movements.
A lawsuit filed in Delaware last week against travel site Tripadvisor and its majority shareholder is highlighting what may be a growing trend.
Penny stocks under $1 to watch before next week. The post Penny Stocks To Buy? 4 Under $1 To Watch Before Next Week appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
Senseonics (SENS) delivered earnings and revenue surprises of 0% and 16.15%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?